Literature DB >> 19567875

Amino acid position-specific contributions to amyloid beta-protein oligomerization.

Samir K Maji1, Rachel R Ogorzalek Loo, Mohammed Inayathullah, Sean M Spring, Sabrina S Vollers, Margaret M Condron, Gal Bitan, Joseph A Loo, David B Teplow.   

Abstract

Understanding the structural and assembly dynamics of the amyloid beta-protein (Abeta) has direct relevance to the development of therapeutic agents for Alzheimer disease. To elucidate these dynamics, we combined scanning amino acid substitution with a method for quantitative determination of the Abeta oligomer frequency distribution, photo-induced cross-linking of unmodified proteins (PICUP), to perform "scanning PICUP." Tyr, a reactive group in PICUP, was substituted at position 1, 10, 20, 30, or 40 (for Abeta40) or 42 (for Abeta42). The effects of these substitutions were probed using circular dichroism spectroscopy, thioflavin T binding, electron microscopy, PICUP, and mass spectrometry. All peptides displayed a random coil --> alpha/beta --> beta transition, but substitution-dependent alterations in assembly kinetics and conformer complexity were observed. Tyr(1)-substituted homologues of Abeta40 and Abeta42 assembled the slowest and yielded unusual patterns of oligomer bands in gel electrophoresis experiments, suggesting oligomer compaction had occurred. Consistent with this suggestion was the observation of relatively narrow [Tyr(1)]Abeta40 fibrils. Substitution of Abeta40 at the C terminus decreased the population conformational complexity and substantially extended the highest order of oligomers observed. This latter effect was observed in both Abeta40 and Abeta42 as the Tyr substitution position number increased. The ability of a single substitution (Tyr(1)) to alter Abeta assembly kinetics and the oligomer frequency distribution suggests that the N terminus is not a benign peptide segment, but rather that Abeta conformational dynamics and assembly are affected significantly by the competition between the N and C termini to form a stable complex with the central hydrophobic cluster.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567875      PMCID: PMC2749133          DOI: 10.1074/jbc.M109.038133

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments.

Authors:  Marcus Fändrich; Vincent Forge; Katrin Buder; Marlis Kittler; Christopher M Dobson; Stephan Diekmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

3.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

4.  Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Authors:  Hai-Wei Wang; Joseph F Pasternak; Helen Kuo; Helen Ristic; Mary P Lambert; Brett Chromy; Kirsten L Viola; William L Klein; W Blaine Stine; Grant A Krafft; Barbara L Trommer
Journal:  Brain Res       Date:  2002-01-11       Impact factor: 3.252

5.  Identification of a mutant amyloid peptide that predominantly forms neurotoxic protofibrillar aggregates.

Authors:  Isam Qahwash; Katherine L Weiland; Yifeng Lu; Ronald W Sarver; Rolf F Kletzien; Riqiang Yan
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

6.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

7.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

Review 8.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

Authors:  Irene H Cheng; Kimberly Scearce-Levie; Justin Legleiter; Jorge J Palop; Hilary Gerstein; Nga Bien-Ly; Jukka Puoliväli; Sylvain Lesné; Karen H Ashe; Paul J Muchowski; Lennart Mucke
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

View more
  37 in total

1.  Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity.

Authors:  Kenjiro Ono; Margaret M Condron; David B Teplow
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.

Authors:  Jeffrey L Cummings; John Ringman; Karen Metz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Globular state in the oligomers formed by Abeta peptides.

Authors:  Seongwon Kim; Takako Takeda; Dmitri K Klimov
Journal:  J Chem Phys       Date:  2010-06-14       Impact factor: 3.488

4.  Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.

Authors:  Giuseppina Andreotti; Rosa Maria Vitale; Carmit Avidan-Shpalter; Pietro Amodeo; Ehud Gazit; Andrea Motta
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

5.  N-Terminal Charged Residues of Amyloid-β Peptide Modulate Amyloidogenesis and Interaction with Lipid Membrane.

Authors:  Clifford Morris; Shirin Cupples; Thomas W Kent; Esmail A Elbassal; Ewa P Wojcikiewicz; Peng Yi; Deguo Du
Journal:  Chemistry       Date:  2018-06-06       Impact factor: 5.236

Review 6.  Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.

Authors:  Qin Nie; Xiao-guang Du; Mei-yu Geng
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

7.  Differences in β-strand populations of monomeric Aβ40 and Aβ42.

Authors:  K Aurelia Ball; Aaron H Phillips; David E Wemmer; Teresa Head-Gordon
Journal:  Biophys J       Date:  2013-06-18       Impact factor: 4.033

8.  Sequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases.

Authors:  David T Hickman; María Pilar López-Deber; Dorin Mlaki Ndao; Alberto B Silva; Deepak Nand; Maria Pihlgren; Valérie Giriens; Rime Madani; Annie St-Pierre; Hristina Karastaneva; Luitgard Nagel-Steger; Dieter Willbold; Detlev Riesner; Claude Nicolau; Marc Baldus; Andrea Pfeifer; Andreas Muhs
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

9.  Residue-Specific Dynamics and Local Environmental Changes in Aβ40 Oligomer and Fibril Formation.

Authors:  Haiyang Liu; Clifford Morris; Richard Lantz; Thomas W Kent; Esmail A Elbassal; Ewa P Wojcikiewicz; Deguo Du
Journal:  Angew Chem Int Ed Engl       Date:  2018-06-14       Impact factor: 15.336

10.  Role of aromatic side chains in amyloid β-protein aggregation.

Authors:  Risto Cukalevski; Barry Boland; Birgitta Frohm; Eva Thulin; Dominic Walsh; Sara Linse
Journal:  ACS Chem Neurosci       Date:  2012-09-24       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.